Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012713
Filing Date
2017-11-09
Accepted
2017-11-09 17:03:33
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 783976
2 ex4-10.htm EX-4.10 60671
3 ex4-11.htm EX-4.11 58301
4 ex4-12.htm EX-4.12 33525
5 ex10-7.htm EX-10.7 74880
6 ex31-1.htm EX-31.1 16700
7 ex32-1.htm EX-32.1 8619
  Complete submission text file 0001493152-17-012713.txt   4767370

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ppch-20170930.xml EX-101.INS 641058
9 XBRL SCHEMA FILE ppch-20170930.xsd EX-101.SCH 49467
10 XBRL CALCULATION FILE ppch-20170930_cal.xml EX-101.CAL 49759
11 XBRL DEFINITION FILE ppch-20170930_def.xml EX-101.DEF 213732
12 XBRL LABEL FILE ppch-20170930_lab.xml EX-101.LAB 334763
13 XBRL PRESENTATION FILE ppch-20170930_pre.xml EX-101.PRE 266107
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 171191754
SIC: 2834 Pharmaceutical Preparations